Comparison of trimetazidine with atenolol in patients with syndrome X: effects on diastolic function and exercise tolerance.

曲美他嗪 医学 阿替洛尔 心脏病学 安慰剂 内科学 心悸 冠状动脉疾病 舒张期 血流动力学 血压 麻醉 病理 替代医学
作者
Filippo Leonardo,Gabriele Fragasso,Enrico Rossetti,P Dabrowski,Paolo Antonio Pagnotta,Giuseppe M.C. Rosano,Sergio Lorenzo Chierchia
出处
期刊:PubMed [National Institutes of Health]
卷期号:44 (12): 1065-1069 被引量:57
链接
标识
摘要

BACKGROUND: Trimetazidine has been shown to improve anginal symptoms without altering hemodynamic variables in patients with coronary artery disease. The aim of this study was to compare the effect of trimetazidine and atenolol upon symptoms, resting left ventricular filling dynamics and exercise tolerance. METHODS: Sixteen patients (3 males, 13 females, mean age 62 +/- 7 years) were randomized to receive trimetazidine for 2 weeks (20 mg 3 times daily) or atenolol (100 mg daily), according to a double-blind, randomized, cross-over, placebo-controlled design. At the end of each treatment period patients underwent symptom-limited exercise testing, an echocardiogram and a Doppler assessment of transmitral flow pattern. Daily life anginal symptoms were annotated on a diary throughout the study. Two patients discontinued trimetazidine because of severe palpitations and only 14 patients completed the study. RESULTS: Atenolol significantly reduced the number of anginal episodes as compared to placebo or trimetazidine (0.44 +/- 0.53, 4.8 +/- 4, 2.9 +/- 4.9, p < 0.01). On atenolol, the exercise test was negative in 8 patients, but none of the patients had a negative test while on trimetazidine. Atenolol increased both time to 1 mm ST segment depression (668 +/- 213 vs 838 +/- 81 s, p < 0.05) and Doppler-derived indices of ventricular filling (E/A ratio 0.87 +/- 0.20 vs 1.21 +/- 0.26, p < 0.05). CONCLUSIONS: These results confirm the beneficial effects of atenolol in improving symptoms, exercise performance and diastolic function in syndrome X patients. Trimetazidine did not exert any significant effect on any of the analyzed variables. Since trimetazidine has been previously shown to improve myocardial ischemia in patients with overt coronary artery disease to a similar extent of beta-blockers, it is likely that other mechanisms are responsible for angina in patients with syndrome X.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
GIN的应助被干净的秋柳采纳,获得10
刚刚
桐桐的应助被哈哈哈采纳,获得30
1秒前
小二郎的应助被结实的秋天采纳,获得10
1秒前
傻丢发布了新的文献求助10
3秒前
舒适鸣凤的应助被大熊采纳,获得10
3秒前
3秒前
su777发布了新的文献求助10
4秒前
4秒前
CodeCraft的应助被甜美虔纹采纳,获得10
5秒前
eternal完成签到,获得积分10
6秒前
温凛完成签到,获得积分10
6秒前
迅速惜海完成签到,获得积分10
7秒前
7秒前
8秒前
槐序完成签到,获得积分10
9秒前
9秒前
限定完成签到 ,获得积分10
10秒前
YLS发布了新的文献求助10
10秒前
10秒前
11秒前
秋风的应助被木木采纳,获得20
11秒前
热情钥匙完成签到,获得积分10
12秒前
liuwenxx发布了新的文献求助30
12秒前
FashionBoy的应助被波波子采纳,获得10
13秒前
yzx关注了科研通微信公众号
13秒前
13秒前
ding的应助被Lisa采纳,获得10
13秒前
jianhua完成签到,获得积分10
14秒前
充电宝的应助被淡定的板栗采纳,获得10
14秒前
科研通AI6.4的应助被Amuro采纳,获得30
15秒前
科研通AI6.3的应助被K9999K采纳,获得10
15秒前
哈哈哈发布了新的文献求助30
16秒前
凹凸曼发布了新的文献求助10
16秒前
李健的应助被江子川采纳,获得10
16秒前
隐形曼青的应助被江子川采纳,获得10
16秒前
科研通AI6.2的应助被江子川采纳,获得10
16秒前
Hqing发布了新的文献求助10
17秒前
科研通AI6.3的应助被江子川采纳,获得10
17秒前
大个的应助被江子川采纳,获得10
17秒前
科研通AI6.2的应助被江子川采纳,获得10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192841
求助须知:如何正确求助?哪些是违规求助? 9579236
关于积分的说明 21864289
捐赠科研通 7792410
什么是DOI,文献DOI怎么找? 3437059
关于科研通互助平台的介绍 2560639
邀请新用户注册赠送积分活动 2483927